Hypercoagulability Completed Phase Trials for Protein C (DB11312)

Also known as: Thrombophilia / Hypercoagulation / Protein C Deficiency / Antithrombin III deficiency

IndicationStatusPhase
DBCOND0035276 (Hypercoagulability)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01127529Ceprotin Treatment Registry
NCT00161720Retrospective Study to Capture Dosing and Treatment Outcome Data in Subjects With Severe Congenital Protein C Deficiency Who Were Treated With Protein C Concentrate Under an Emergency Use IND